Up

Opportunities for Accelerating AIDS Vaccine R&D in China

This policy brief, produced through a collaboration between IAVI, the Department of Medical Sciences, Technology and Education of China's Ministry of Health and McKinsey and Co., explores how targeted policy reforms focused on strengthening collaboration, sustaining government financing, incentivizing private investment and improving the regulatory and IP environment could accelerate China's participation in AIDS vaccine R&D.


Opportunities for Accelerating AIDS Vaccine R&D in China
File Size:
1.19 MB